Myopericarditis is a rare consequence of COVID-19 infection. Although extremely rare, COVID-19 can present without pulmonary involvement, and there have been reports of isolated cardiac involvement in one prior case
We report a case of a young African American man presenting with myopericarditis following a recently recovered COVID-19 infection. Complicated by ICU admission requiring vasopressors; with eventual resolution following initiation of aspirin and colchicine for myopericarditis.
Life threatening myopericarditis can occur following resolution of COVID-19 disease. The degree of cardiac involvement correlates poorly to the severity of pulmonary involvement.
Dr. Steven Mirabella is an industrious 3rd year Internal Medicine Resident completing training at a busy New York hospital in Long Island. He has extensive clinical experience managing COVID-19 infection. He has given multiple poster presentations at the American College of Physicians (ACP) Scientific meetings; as well as the 15th Annual Medical Society of the State of New York (MSSNY) Resident/ Fellow Poster Symposium in Tarrytown New York. Most recently he was awarded first place along with his colleagues at the 2021 American College of Osteopathic Internists (ACOI) Resident/Fellow Case Presentation Contest in Orlando, Florida, USA. He was enthralled to be able to share his recently published work and experience with such a wide audience.